重视结核病相关疾病的整合医学管理

doi:10.19982/j.issn.1000-6621.20240173

摘要/Abstract

中图分类号:

R521

曾谊, 兰学立, 路希维. 重视结核病相关疾病的整合医学管理[J]. 中国防痨杂志, 2024, 46(7): 735-738. doi: 10.19982/j.issn.1000-6621.20240173

参考文献 32

[1]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1): 12-22. doi:10.3969/j.issn.1000-6621.2021.01.004.
[2]	Meng F, Lan L, Wu G, et al. Impact of diabetes itself and glycemic control status on tuberculosis. Front Endocrinol (Lausanne), 2023, 14: 1250001. doi:10.3389/fendo.2023.1250001.
[3]	Rehman AU, Khattak M, Mushtaq U, et al. The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis. Front Public Health, 2023, 11: 1244450. doi:10.3389/fpubh.2023.1244450.
[4]	Liu YH, Guo Y, Xu H, et al. Impact of Non-Alcoholic Simple Fatty Liver Disease on Antituberculosis Drug-Induced Liver Injury. Infect Drug Resist, 2021, 14: 3667-3671. doi:10.2147/IDR.S326386.
[5]	Baluku JB, Nuwagira E, Bongomin F, et al. Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities. Int J Tuberc Lung Dis, 2021, 25(7): 537-546. doi:10.5588/ijtld.21.0034. pmid: 34183098
[6]	Page ID, Byanyima R, Hosmane S, et al. Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. Eur Respir J, 2019, 53(3): 1801184. doi:10.1183/13993003.01184-2018.
[7]	Denning DW, Page ID, Chakaya J, et al. Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings. Emerg Infect Dis, 2018, 24(8): e171312. doi:10.3201/eid2408.171312.
[8]	Denning DW, Cole DC, Ray A. New estimation of the prevalence of chronic pulmonary aspergillosis (CPA) related to pulmonary TB-a revised burden for India. IJID Reg, 2022, 6: 7-14. doi:10.1016/j.ijregi.2022.11.005.
[9]	Bongomin F, Olum R, Kibone W, et al. Prevalence of chronic pulmonary aspergillosis along the continuum of pulmonary tuberculosis care: A protocol for a living systematic review and meta-analysis. PLoS One, 2023, 18(12): e0294634. doi:10.1371/journal.pone.0294634.
[10]	郭静, 沈银忠. HIV感染/AIDS合并结核病的临床及免疫学特点研究进展. 诊断学理论与实践, 2021, 20(4): 401-406. doi:10.16150/j.1671-2870.2021.04.014.
[11]	World Health Organization. WHO operational handbook on tuberculosis (Module 1: prevention): tuberculosis preventivetreatment. Geneva: World Health Organization, 2020.
[12]	World Health Organization. Consolidated Guidelines on HIV Prevention, Testing, Treatment,Service Delivery and Monitoring: Recommendations for a Public Health Approach. Geneva: World Health Organization, 2021.
[13]	Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV[EB/OL].[2024-04-29]. https://clinicalinfo.hiv.gov/en/guidelines/adult-andadolescent-opportunistic-infection.
[14]	Namale PE, Abdullahi LH, Fine S, et al. Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis. Future Microbiol, 2015, 10(6): 1077-1099. doi:10.2217/fmb.15.9. pmid: 26059627
[15]	Meintjes G, Stek C, Blumenthal L, et al. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS. N Engl J Med, 2018, 379(20): 1915-1925. doi:10.1056/NEJMoa1800762.
[16]	World Health Organization. WHO consolidated guidelines on tuberculosis:Module 1:prevention: tuberculosis preventive treatment. Geneva: World Health Organization, 2020.
[17]	Shachor Y, Schindler D, Siegal A, et al. Increased incidence of pulmonary tuberculosis in chronic interstitial lung disease. Thorax, 1989, 44(2): 151-153. doi:10.1136/thx.44.2.151. pmid: 2929001
[18]	Chung MJ, Goo JM, Im JG. Pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis. Eur J Radiol, 2004, 52(2): 175-179. doi:10.1016/j.ejrad.2003.11.017. pmid: 15489076
[19]	Wong C, Sahni S, Cheema MAI, et al. Mycobacterium tuberculosis Infection in the Setting of Interstitial Lung Disease: Coincidence or Bad Luck?. Cureus, 2018, 10(10): e3391. doi:10.7759/cureus.3391.
[20]	Lee YH, Cha SI, Lim JK, et al. Clinical and radiological features of pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis. Respir Investig, 2019, 57(6): 544-551. doi:10.1016/j.resinv.2019.08.001.
[21]	Ogawa K, Kurosaki A, Miyamoto A, et al. Clinicoradiological Features of Pulmonary Tuberculosis with Interstitial Pneumonia. Intern Med, 2019, 58(17): 2443-2449. doi:10.2169/internalmedicine.2341-18.
[22]	Shah SN, Gajwani BW, Dave BT. Idiopathic diffuse interstitial lung disease with tuberculosis. Indian J Chest Dis, 1967, 9(4):229-232. pmid: 5633706
[23]	Dias VL, Storrer KM. Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression. J Bras Pneumol, 2022, 48(2): e20210382. doi:10.36416/1806-3756/e20210382.
[24]	Moran E, Baharani J, Dedicoat M, et al. Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease. J Infect, 2018, 77(4): 291-295. doi:10.1016/j.jinf.2018.06.003. pmid: 29928915
[25]	GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990—2017: a systematic analysis for the Global Burden of Disease Study 2017, 2020, 395(10225): 709-733. doi:10.1016/S0140-6736(20)30045-3.
[26]	Alemu A, Bitew ZW, Diriba G, et al. Tuberculosis incidence in patients with chronic kidney disease: a systematic review and meta-analysis. Int J Infect Dis, 2022, 122: 188-201. doi:10.1016/j.ijid.2022.05.046. pmid: 35609860
[27]	Vikrant S. Tuberculosis in dialysis: Clinical spectrum and outcome from an endemic region. Hemodial Int, 2019, 23(1): 88-92. doi:10.1111/hdi.12693. pmid: 30289617
[28]	Vikrant S. Clinical profile of tuberculosis in patients with chronic kidney disease: A report from an endemic Country. Saudi J Kidney Dis Transpl, 2019, 30(2):470-477. doi:10.4103/1319-2442.256854. pmid: 31031383
[29]	中国医院协会血液净化中心管理分会专家组. 中国成人慢性肾脏病合并结核病管理专家共识. 中国血液净化, 2016, 15(11): 577-586. doi:10.3969/j.issn.1671-4091.2016.11.001.
[30]	British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee, Milburn H, Ashman N, et al. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax, 2010, 65(6): 557-570. doi:10.1136/thx.2009.133173.
[31]	中华医学会结核病学分会. 慢性肾脏病合并结核病的治疗专家共识(2022版). 中华结核和呼吸杂志, 2022, 45(10):996-1008. doi:10.3760/cma.j.cn112147-20220327-00241.
[32]	Xiao J, Ge J, Zhang D, et al. Clinical Characteristics and Outcomes in Chronic Kidney Disease Patients with Tuberculosis in China: A Retrospective Cohort Study. Int J Gen Med, 2022, 15: 6661-6669. doi:10.2147/IJGM.S367090. pmid: 36016982

重视结核病相关疾病的整合医学管理

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 32

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	中国防痨协会结核病控制专业分会, 中国防痨协会青年分会, 《中国防痨杂志》编辑委员会. 中国结核病数字服药依从性技术应用指南[J]. 中国防痨杂志, 2025, 47(4): 385-397.
[2]	吴璇, 张艳秋, 徐吉英, 孟丹, 孙定勇. 2019—2023年河南省肺结核合并糖尿病患者治疗转归影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 425-431.
[3]	柳晓蕾, 王海慧, 张汝姣, 崔蓉, 王凯, 田高清. 非结核分枝杆菌肺病并发肺曲霉菌病一例[J]. 中国防痨杂志, 2025, 47(1): 116-120.
[4]	张丽帆, 陈艳, 张月秋, 张奉春, 曾小峰, 赵岩, 刘升云, 左晓霞, 张志毅, 吴华香, 陈盛, 李鸿斌, 朱平, 武丽君, 齐文成, 刘毅, 张缪佳, 刘花香, 周宝桐, 侍效春, 阮桂仁, 刘晓清, 中国风湿免疫病人群活动性结核病的流行病学调查和治疗效果及预后研究课题组. 中国风湿免疫病患者活动性结核病患病情况多中心横断面研究:亚组分析[J]. 中国防痨杂志, 2025, 47(1): 22-28.
[5]	《脊柱结核并发HIV/AIDS患者诊断及治疗专家共识》编写组, 中国防痨协会骨关节结核专业分会, 中国性病艾滋病防治协会艾滋病外科专业委员会, 中国西部骨结核联盟, 中国华北骨结核联盟. 脊柱结核并发HIV/AIDS患者诊断及治疗专家共识(第2版)[J]. 中国防痨杂志, 2025, 47(1): 1-11.
[6]	张国钦, 曲婷, 孟庆琳, 周林, 刘二勇. 我国结核病合并HIV/AIDS双重感染防治策略的实施进展[J]. 中国防痨杂志, 2025, 47(1): 12-17.
[7]	鲍添, 高婉君, 宗隽绅, 蔡倩. 优质护理理念在妊娠合并肺炎患者中的运用效果[J]. 中国防痨杂志, 2024, 46(S2): 443-445.
[8]	张德欣, 金烈. IgG4相关肾病合并肺部感染二例并文献复习[J]. 中国防痨杂志, 2024, 46(S2): 553-555.
[9]	杨梁梓, 张培泽, 卢水华. 世界卫生组织《耐药结核病和丙型病毒性肝炎治疗的联合管理(2024快讯版)》解读[J]. 中国防痨杂志, 2024, 46(8): 874-876.
[10]	鲍丙丽, 刘红丹, 杜桂春. 重症耐药肺结核合并糖尿病酮症酸中毒患者体外膜肺氧合及有创机械通气的护理一例[J]. 中国防痨杂志, 2024, 46(8): 982-986.
[11]	蔡清河, 符慧, 陈蕊明, 樊友铭, 杨清伟. 2016—2022年汕头市肺结核合并糖尿病患者临床特征及其影响因素分析[J]. 中国防痨杂志, 2024, 46(8): 926-934.
[12]	傅可言, 朱邦政, 叶健. 间质性肺疾病合并结核分枝杆菌感染的研究进展[J]. 中国防痨杂志, 2024, 46(7): 823-829.
[13]	柴冬雨, 秦淑一, 张荣花, 邹楠楠, 王欣. 病毒性肺炎合并侵袭性肺真菌病的危险因素分析[J]. 中国防痨杂志, 2024, 46(7): 750-755.
[14]	李瑶, 方喆, 罗丹霖, 胡艳梅, 唐蜜, 唐志冈, 文新民, 张勇, 姚碧波, 王起, 易恒仲. 新型冠状病毒感染合并肺结核患者的临床特征和预后情况分析[J]. 中国防痨杂志, 2024, 46(6): 687-698.
[15]	刘桂珍, 邓国防. 《结核病政策指南制订过程中发现的证据和研究缺口(第2版)》解读——结核病相关共病[J]. 中国防痨杂志, 2024, 46(6): 618-624.